News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com4d agoneutral
Ocugen Inc (OCGN) Q3 2026 Earnings Call Highlights: Three Gene Therapy Programs Reach Phase 3 ...GlobeNewswire4d agoneutral
Ocugen Provides Business Update with Third Quarter 2026 Financial ResultsGlobeNewswire10d agoneutral
Ocugen to Participate in Upcoming November Investor and Industry ConferencesGlobeNewswire17d agoneutral
Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4GlobeNewswire33d agoneutral
Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European AffiliateGlobeNewswire40d agoneutral
Ocugen to Participate in Upcoming October Investor and Industry ConferencesMarketBeat53d agoneutral
Ocugen Targets Three Gene Therapy BLA Filings as Retinal Pipeline AdvancesMarketBeat85d agoneutral
Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key ReadoutsGuruFocus.com94d agoneutral
Ocugen Inc (OCGN) (Q2 2026) Earnings Call Highlights: FDA Clearance for OCU410 Phase 3 Trial ...MarketBeat121d agoneutral
Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline AdvancesSimply Wall St.137d agoneutral
Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View